Blood test breakthrough could spot deadly heart disease years earlier
NCT ID NCT07314268
Summary
This study aims to find better ways to detect heart damage from ATTR amyloidosis, a condition where abnormal proteins build up in the heart. Researchers will analyze tiny particles in the blood of 70 people, including those with the disease, those at risk, and healthy individuals, to see if these particles can serve as early warning signs. The goal is to help doctors diagnose the condition sooner, before significant heart damage occurs, to improve patient care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYLOIDOSIS CARDIAC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Instituto do Coracao, HCFMUSP
RECRUITINGSão Paulo, São Paulo, 05403000, Brazil
Contact
Contact
Contact Phone: •••-•••-••••
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.